Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew S Allegretti

Showing results (1-10 of 100) with videos related to

Pageof 10
Sort By:
Clinical and Translational Gastroenterology|July 12, 2021
Response to WengAndrew S Allegretti,
Kidney360|March 25, 2024
Use of Terlipressin in AKI Associated with Hepatorenal Syndrome: COMMENTARYAndrew S Allegretti
Kidney Medicine|February 19, 2021
Acute Kidney Injury Treatment in Decompensated Cirrhosis: A Focus on Kidney Replacement TherapyAndrew S Allegretti
Hepatology (Baltimore, Md.)|September 28, 2022
NGAL in AKI and cirrhosis-Ready for prime time?Andrew S Allegretti
Kidney360|April 4, 2022
Bile Acids Are Important Contributors to AKI Associated with Liver Disease: CONAndrew S Allegretti, Justin M Belcher
Kidney360|March 20, 2025
Physiologic Solutions are Superior to Normal Saline in Critically Ill Patients: CONAndrew Z Fenves, Andrew S Allegretti
Nature Reviews. Nephrology|March 27, 2018
Epidemiology: Chronic disease, cancer, and exercise - a common linkAndrew S Allegretti, Ravi I Thadhani
Kidney360|April 4, 2022
Dialysis Filter Life in COVID-19: Early Lessons from the PandemicIgnacio Portales-Castillo, Andrew S Allegretti
Alimentary Pharmacology & Therapeutics|October 29, 2020
Letter: HRS-AKI-a frequent misdiagnosis in the real world setting? Authors' replyKevin Moore, Khurram Jamil, Andrew S Allegretti
Alimentary Pharmacology & Therapeutics|July 8, 2021
Letter: real-world use of terlipressin in patients with the hepatorenal syndrome-authors' replyAndrew S Allegretti, Khurram Jamil, Kevin Moore
Pageof 10

Showing results (1-10 of 100) with videos related to

Sort By:
Pageof 10
Clinical and Translational Gastroenterology|July 12, 2021
Response to WengAndrew S Allegretti,
Kidney360|March 25, 2024
Use of Terlipressin in AKI Associated with Hepatorenal Syndrome: COMMENTARYAndrew S Allegretti
Kidney Medicine|February 19, 2021
Acute Kidney Injury Treatment in Decompensated Cirrhosis: A Focus on Kidney Replacement TherapyAndrew S Allegretti
Hepatology (Baltimore, Md.)|September 28, 2022
NGAL in AKI and cirrhosis-Ready for prime time?Andrew S Allegretti
Kidney360|April 4, 2022
Bile Acids Are Important Contributors to AKI Associated with Liver Disease: CONAndrew S Allegretti, Justin M Belcher
Kidney360|March 20, 2025
Physiologic Solutions are Superior to Normal Saline in Critically Ill Patients: CONAndrew Z Fenves, Andrew S Allegretti
Nature Reviews. Nephrology|March 27, 2018
Epidemiology: Chronic disease, cancer, and exercise - a common linkAndrew S Allegretti, Ravi I Thadhani
Kidney360|April 4, 2022
Dialysis Filter Life in COVID-19: Early Lessons from the PandemicIgnacio Portales-Castillo, Andrew S Allegretti
Alimentary Pharmacology & Therapeutics|October 29, 2020
Letter: HRS-AKI-a frequent misdiagnosis in the real world setting? Authors' replyKevin Moore, Khurram Jamil, Andrew S Allegretti
Alimentary Pharmacology & Therapeutics|July 8, 2021
Letter: real-world use of terlipressin in patients with the hepatorenal syndrome-authors' replyAndrew S Allegretti, Khurram Jamil, Kevin Moore
Pageof 10